Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review

Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. The company has manufacturing facilities in India and the US. It operates in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc Key Recent Developments

Feb 26,2020 Akorn provides fourth quarter and full year 2019 results
Oct 31,2019 Akorn provides preliminary third quarter 2019 results
Aug 01,2019 Akorn provides preliminary second quarter 2019 results
Jul 30,2019 Akorn signs $74m settlement with investors over data integrity problems

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Akorn Inc - Key Facts
Akorn Inc - Key Employees
Akorn Inc - Key Employee Biographies
Akorn Inc - Major Products and Services
Akorn Inc - History
Akorn Inc - Company Statement
Akorn Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Akorn Inc - Business Description
Business Segment: Consumer Health
Overview
Performance
Business Segment: Prescription Pharmaceuticals
Overview
Performance
Akorn Inc - Corporate Strategy
Akorn Inc - SWOT Analysis
SWOT Analysis - Overview
Akorn Inc - Strengths
Akorn Inc - Weaknesses
Akorn Inc - Opportunities
Akorn Inc - Threats
Akorn Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Akorn Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 26, 2020: Akorn provides fourth quarter and full year 2019 results
Oct 31, 2019: Akorn provides preliminary third quarter 2019 results
Aug 01, 2019: Akorn provides preliminary second quarter 2019 results
Jul 30, 2019: Akorn signs $74m settlement with investors over data integrity problems
Jun 25, 2019: Akorn receives FDA warning letter related to the inspection of its Somerset, New Jersey manufacturing facility
Jun 13, 2019: Akorn receives warning letter from FDA
May 07, 2019: Akorn provides preliminary first quarter 2019 results and full year guidance
Mar 21, 2019: Akorn names Erislandy (Dandy) Dorado-Boladeres as executive vice president of global quality
Mar 01, 2019: Akorn comments on favorable court order
Feb 28, 2019: Akorn provides fourth quarter and full year 2018 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Akorn Inc, Key Facts
Akorn Inc, Key Employees
Akorn Inc, Key Employee Biographies
Akorn Inc, Major Products and Services
Akorn Inc, History
Akorn Inc, Other Locations
Akorn Inc, Subsidiaries
Akorn Inc, Joint Venture
Akorn Inc, Key Competitors
Akorn Inc, Ratios based on current share price
Akorn Inc, Annual Ratios
Akorn Inc, Annual Ratios (Cont...1)
Akorn Inc, Annual Ratios (Cont...2)
Akorn Inc, Interim Ratios
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Akorn Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


Akorn Inc, Performance Chart (2015 - 2019)
Akorn Inc, Ratio Charts
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Akorn Inc Strategic Analysis Review- Akorn Inc SWOT, Outlook, Operations and Financial Profile

Akorn Inc Company Profile provides strategic analysis of Akorn Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200 View Report

Akorn Inc (AKRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal

USD 250 View Report

Akorn Inc Strategic Analysis Review- Akorn Inc SWOT, Outlook, Operations and Financial Profile

Akorn Inc Company Profile provides strategic analysis of Akorn Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200 View Report

Akorn Inc (AKRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available